PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $458,000 | -28.5% | 91,069 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $641,000 | +17.6% | 91,069 | +28.9% | 0.01% | +60.0% |
| Q4 2014 | $545,000 | +101.9% | 70,625 | +95.1% | 0.01% | +150.0% |
| Q3 2014 | $270,000 | -22.9% | 36,205 | 0.0% | 0.00% | -86.7% |
| Q2 2014 | $350,000 | -8.4% | 36,205 | -21.3% | 0.02% | -11.8% |
| Q1 2014 | $382,000 | -4.7% | 45,993 | -3.2% | 0.02% | +70.0% |
| Q4 2013 | $401,000 | -21.4% | 47,529 | -25.8% | 0.01% | -33.3% |
| Q3 2013 | $510,000 | +12.1% | 64,043 | +8.7% | 0.02% | +150.0% |
| Q2 2013 | $455,000 | – | 58,926 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |